migraine-treatments > 공지사항

본문 바로가기

공지사항

공지사항

migraine-treatments

페이지 정보

profile_image
작성자 Darryl McCollis…
댓글 0건 조회 2회 작성일 26-07-10 11:49

본문

Migraines Treatment


What is Chronic Migraine?


Chronic migraine is defined as experiencing headaches on 15 or more days per month, with at least 8 days having migraine features, for more than 3 months. This condition significantly impacts quality of life, work productivity, and daily functioning.


The Science Behind Botox for Migraine


Botox works by blocking the release of certain neurotransmitters involved in pain transmission. Specifically, it:


Inhibits the release of pain-related neuropeptides and neurotransmitters (such as substance P, CGRP, and glutamate)


Prevents peripheral sensitisation of pain nerve endings


Reduces the of central pain processing pathways


Relaxes muscles that may contribute to tension-type headache components


Prices




Treatment




£800




Further Treatment




£300


The standardised injection technique for Botox in chronic migraine treatment is based on the PREEMPT (Phase III Research Evaluating Migraine Prophylaxis Therapy) clinical trials. This protocol established the specific injection sites, dosing, and administration that demonstrated efficacy in treating migraine.


Fixed-site, fixed-dose approach: The protocol specifies 31 mandatory injection sites across 7 key head and neck muscle areas, with a total of 155 units of Botox


Follow-the-pain strategy: Up to 40 additional units may be administered in areas where patients the most pain, allowing for individualised treatment


Bilateral injections: Injections are administered on both sides of the head and neck


Shallow intramuscular technique: Precise injection depth and angle to target specific muscle groups


Evidence-based effectiveness: This approach was through large-scale clinical trials showing significant reduction in headache days


The PREEMPT protocol targets these muscle groups:


Frontalis: muscles (10 units divided between both sides)


Corrugator: Muscles between the eyebrows (10 units between both sides)


Procerus: Bridge of the nose (5 units)


Occipitalis: Back of the head (30 units divided between both sides)


Temporalis: Temple area (40 units divided between both sides)


Trapezius: Upper back/shoulder (30 units divided between both sides)


Cervical paraspinal: Neck muscles (20 units divided between both sides)


This systematic approach consistent treatment delivery and replicates the conditions under which Botox was proven effective in clinical trials.


FAQs




Benefits of Botox for Chronic Migraine




Proven efficacy: Strong clinical evidence supporting its effectiveness in reducing migraine frequency and severity


Reduced medication burden: May decrease the need for acute migraine medications and reduce the risk of medication overuse headache


Favourable safety profile: Generally well-tolerated with minimal systemic side effects compared to oral preventive medications


Convenient dosing: Requires treatment only four times per year


Quality of life improvements: Significant improvements in disability, work productivity, and overall well-being


Non-systemic treatment: Works locally without requiring daily oral medication


No drug interactions: Does not interact with most other medications




Limitations for Botox for Chronic Migraine




Time to effect: May take 2-3 treatment cycles (6-9 months) to achieve optimal results


Ongoing commitment: Requires regular appointments every 12 weeks


Not effective for everyone: Approximately 60-70% of patients respond to treatment


Temporary effects: Benefits wear off over time, requiring continued treatment




Potential Side Effects from the Migraine Treatment




Common Side Effects


Most side effects are mild and temporary:


Neck pain or stiffness (most common)


Headache (may occur initially before improvement)


Muscle weakness in the neck or shoulders


Drooping eyelid (ptosis) - rare and temporary


Injection site pain, bruising, or swelling


Flu-like symptoms



Rare but Serious Side Effects


Though uncommon, patients should be aware of:


Difficulty swallowing or breathing


Speech problems


Severe muscle weakness


Allergic reactions


Patients should contact us immediately if they any concerning symptoms.




NHS Perspective on Botox for Chronic Migraine




The NHS recognises Botox as an evidence-based treatment for chronic migraine, supported by NICE guidance (TA260) from 2012. Access is restricted to patients who meet specific criteria: confirmed chronic migraine diagnosis (15+ headache days per month), failure of at least three oral preventive medications, of any medication overuse, and specialist . Treatment is provided free when approved, typically with a 6-month trial period. However, availability varies significantly by region and CCG, with potential waiting times for assessment and treatment.


While the NHS recognises Botox as evidence-based for chronic migraine, access can be limited by strict eligibility criteria, regional variations, and lengthy waiting times. At Karwal Aesthetics, we are a private provider and do not work with the NHS. We offer migraine treatments at out London, Mayfair clinic.




Migraine Treatment Success Rates and Expectations




Clinical data shows:


Response rate: Approximately 60-70% of patients experience a meaningful reduction in headache days


reduction: 8-9 fewer headache days per month


Improvement timeline: Gradual improvement over the first 2-3 treatment cycles


benefits: Many patients maintain improvement with continued treatment over several years


Acute medication use: Significant reductions in the need for pain-relieving medications




How is the Treatment Performed?




Consultation: A thorough assessment is performed to confirm the diagnosis of chronic migraine and to rule out other causes of headache.


Preparation: The skin is cleansed. No anaesthetic is usually required as the injections are quick and use a very fine needle.


Injection Sites: Botox is at multiple sites across the head and neck, following a standardised protocol known as the PREEMPT (Phase III Research Evaluating Migraine Prophylaxis Therapy) protocol.


Typical areas include the forehead, temples, back of the head (occipital region), neck, and shoulders.


In total, around 31–39 injections are given in one session.


Procedure Time: The treatment takes About Laser Hair Removal for Women 15–20 minutes.


Aftercare: Patients can return to normal activities immediately, though it’s best to avoid strenuous exercise for 24 hours.




Where is Botox Injected for Migraines?




Botox is injected into seven key muscle areas around the head and neck, including:


Forehead (frontalis muscle)


( muscle)


Back of the head (occipitalis muscle)


Neck (cervical paraspinal and trapezius muscles)


Above the ears (temporalis)


Bridge of the nose (procerus)


Upper shoulders (trapezius)


This multi-site approach targets the nerves and muscles most commonly involved in migraine attacks.




Who Should Consider Botox Treatment for Migraines?




The ideal candidate for Botox migraine treatment typically:


Has chronic migraine: Experiences headaches on 15 or more days per month, with at least 8 days having migraine features


Has not responded adequately to other treatments: Has tried at least 2-3 oral preventive medications without sufficient benefit


Experiences significant disability: Migraine substantially impacts work, school, or daily activities


Is 18 years or older: Botox for chronic migraine is approved for adult patients


Can commit to regular treatment: to attend appointments every 12 weeks


Has realistic expectations: Understands that results may take several months to manifest




Regulatory Approval and Clinical Recognition




Botulinum toxin type A, commonly known as Botox, has emerged as an effective preventive treatment for chronic migraine. Initially approved by the FDA in 2010 for this indication, Botox represents a significant advancement in migraine management for patients who experience frequent and debilitating headaches.


The NHS recognises Botox as an evidence-based treatment for chronic migraine, supported by NICE guidance (TA260) from 2012. This dual recognition from both American and British regulatory authorities the robust clinical evidence supporting Botox as a legitimate therapeutic option for migraine .




Where we offer migraine treatments?




Migraine treatments are performed at our Mayfair Clinic, 15 Dover Street, W1s 4LP.




Who May Not Be for this Treatment




Botox may not be appropriate for individuals who:


Have episodic (fewer than 15 headache days per month)


Are pregnant, planning to become pregnant, or breastfeeding


Have certain neuromuscular disorders (such as myasthenia gravis or Lambert-Eaton syndrome)


Have allergies to botulinum toxin or any ingredients in the formulation


Have an infection at the proposed injection sites


Are taking certain medications that may interact with Botox




Business Enquiries



Mayfair, London
2nd Floor, 15 Dover Street, W1S 4LP


Closed
10: :00
10: :00
10: :00
10: :00
Select Dates
Closed


Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday


0% finance is available on all from £500. Find out more by visiting our Payment Plan page.


Please note: our clinic is on the second floor with stair access only.


Copyright © 2026 Karwal . All rights reserved.

댓글목록

등록된 댓글이 없습니다.

회원로그인


  • 바다커뮤니케이션즈
  • 서울특별시 강남구 영동대로 602, 6층 g157호
  • TEL : 02-6954-7866
  • E-mail : badabizline@badacomms.com
  • 사업자등록번호 : 891-22-00581
Copyright © BadaBizline All rights reserved.